title: Rapidly growing pancreatic ductal adenocarcinoma in a patient with metastatic melanoma and harbouring CDKN2A germline mutation: a new vemurafenib-induced malignancy?
authors.forename: Sophie
authors.initials: S
authors.lastname: Lipowicz
authors.forename: Sophie
authors.initials: S
authors.lastname: Chagnon
authors.forename: Philippe
authors.initials: P
authors.lastname: Saiag
mesh_terms: D000328:Adult; D021441:Carcinoma, Pancreatic Ductal / Q000139:chemically induced* / Q000235:genetics / Q000473:pathology; D019942:Genes, p16; D018095:Germ-Line Mutation; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000235:genetics* / Q000473:pathology; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000139:chemically induced* / Q000235:genetics / Q000473:pathology; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib